David J. Sullivan, Ph.D. has been appointed vice president, Quality Operations at ANI Pharmaceuticals, Inc. Dr. Sullivan joined the company in April 2014 from Boston Scientific where he was responsible for cGMP labs, quality engineering, and systems. Prior to his nine years at Boston Scientific, he worked in quality operations for pharmaceutical firms, including Abbvie (formerly Solvay Pharmaceuticals) as a research scientist.
 
Arthur S. Przybyl, president and chief executive officer said, “We are delighted to announce the promotion of Dave to head ANI’s Quality Operations. He joined ANI in April of last year from a very successful career at Boston Scientific and has already proven to be an outstanding addition to our quality team. Our manufacturing facilities have an exemplary quality track record through both FDA and customer inspections and we continually seek to raise the bar on cGMP in our plants.”

Dr. Sullivan replaces Robert Jamnick, who is retiring after 30 years with the company.
 
Mr. Przybyl noted, “Everyone at ANI wishes Bob all the best in his well-deserved retirement. Since I joined ANI in 2009, he has been a critical member of the senior management team and his focus on ensuring a foundation of quality to support our growth has been an important contributor to the success ANI enjoys today. The Board of Directors joins me in offering our sincere thanks to Bob for his many years of service.”